Accretion Nutraveda Limited will conduct its 5th Annual General Meeting (AGM) on Thursday, August 27, 2026, using the Video-Conferencing / Other Audio Visual Means (VC/OAVM) facility. The meeting is scheduled to begin at 02:00 P.M. IST, enabling shareholders to attend and vote without physical presence, a measure permitted under specific regulatory circulars issued by the Ministry of Corporate Affairs (MCA). This approach ensures broader shareholder participation while adhering to compliance norms set by the Securities and Exchange Board of India (SEBI).

The company notified stakeholders of this arrangement through newspaper advertisements published on August 1, 2026, in Business Standard (English) and Jai Hind (Gujarati). These publications were made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with MCA Circular no. 20/2020 dated May 5, 2020, and subsequent circulars nos. 14/2020, 17/2020, and 03/2025. The latter circulars, dated April 8, 2020, April 13, 2020, and September 22, 2025, respectively, provide the legal framework for holding general meetings via electronic means.

Meeting Details and Shareholder Participation

Shareholders are advised that the annual report for the financial year 2023-24 will be dispatched electronically to those who have registered their email addresses with the company or their Depository Participants. For shareholders who have not provided email IDs, the annual report and notice of the AGM will be available for download on the company’s website at www.accretionnutraveda.com . Additionally, these documents will be hosted on the website of BSE Limited ( www.bseindia.com ) and the Central Depository Services Limited (CDSL) e-voting portal ( www.evotingindia.com ).

The company is facilitating remote e-voting for all shareholders holding shares as on the record date. Those who wish to vote before the meeting can do so via the remote e-voting facility. Shareholders who have not cast their votes prior to the AGM will also have the opportunity to vote electronically during the live session of the meeting. This dual voting mechanism aims to maximize shareholder engagement and ensure that all eligible votes are counted accurately.

Regulatory Compliance and Documentation

The decision to hold the AGM via VC/OAVM aligns with the ongoing regulatory push towards digital governance and transparency in corporate proceedings. By leveraging technology, Accretion Nutraveda Limited ensures that its corporate actions remain accessible to all investors, regardless of their geographical location. The company secretary and compliance officer, Payal Kotadiya, confirmed that all procedural requirements under the Companies Act and SEBI regulations have been met.

Shareholders requiring assistance with the e-voting process can refer to the Frequently Asked Questions (FAQs) and e-voting manual available on the CDSL website. Alternatively, they may contact Rakesh Dalvi, Assistant Vice President at CDSL, or reach out to the helpdesk at helpdesk.evoting@cdslindia.com . A toll-free number, 1800 22 55 33, is also available for support during normal business hours.

What the Numbers Show

While this announcement is procedural in nature, it reflects the company's adherence to strict regulatory timelines and digital adoption standards. The use of VC/OAVM facilities has become standard practice post-pandemic, reducing logistical costs and carbon footprint associated with physical meetings. For Accretion Nutraveda Limited, maintaining compliance with multiple MCA circulars demonstrates a robust corporate governance framework, which is critical for sustaining investor confidence and regulatory standing.

Accretion Nutraveda Limited has informed BSE Limited about an upcoming Board of Directors meeting scheduled for May 8, 2026. The meeting intimation was filed on May 1, 2026, in accordance with regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The board meeting has been convened primarily to consider and approve the company's audited financial results for the fiscal year that concluded on March 31, 2026. This represents a crucial milestone for stakeholders as it will provide comprehensive insights into the company's financial performance for FY26.

Company Information

Accretion Nutraveda Limited, formerly known as Accretion Nutraveda Private Limited, is listed on BSE Limited with scrip code 544694. The company secretary and compliance officer, Payal Kotadiya, signed the board meeting intimation digitally on May 1, 2026.

Regulatory Compliance

The intimation follows the mandatory disclosure requirements under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where financial results are scheduled for consideration and approval.

The upcoming board meeting represents a standard corporate governance practice, ensuring transparency and timely disclosure of financial information to investors and regulatory authorities.